BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185]
URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4185.htm
Number Citing Articles
1
Nutrition and Cancer2013; : 221 doi: 10.1002/9781118788707.ch12
2
J. Skipworth, J. Foster, D. Raptis, F. Hughes. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinomaDiseases of the Esophagus 2009; 22(7): 559 doi: 10.1111/j.1442-2050.2009.00939.x
3
D. Tougeron, M. Scotté, H. Hamidou, F. Di Fiore, B. Paillot, F. Michot, P. Michel. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?Journal of Surgical Oncology 2012; 105(8): 761 doi: 10.1002/jso.22157
4
Stéphane Lecleire, Frédéric Di Fiore, Michel Antonietti, Emmanuel Ben-Soussan, Patrick Hochain, Eric Lerebours, Pierre Michel, Philippe Ducrotté. Nonoperable Patients With Superficial Esophageal Cancer Treated by Photodynamic Therapy After Chemoradiotherapy Have More Severe Complications Than Patients Treated in Primary IntentThe American Journal of Gastroenterology 2008; 103(9): 2215 doi: 10.1111/j.1572-0241.2008.02042.x
5
Sonia A. Duffy, David L. Ronis, Scott McLean, Karen E. Fowler, Stephen B. Gruber, Gregory T. Wolf, Jeffrey E. Terrell. Pretreatment Health Behaviors Predict Survival Among Patients With Head and Neck Squamous Cell CarcinomaJournal of Clinical Oncology 2009; 27(12): 1969 doi: 10.1200/JCO.2008.18.2188
6
A. Duclos, F. Di Fiore, S. Lecleire, P. Michel. Predictive and prognostic factors in patients with an oesophageal carcinoma treated with chemoradiotherapy: The key role of nutritional parametersGastroentérologie Clinique et Biologique 2009; 33(6-7): 491 doi: 10.1016/j.gcb.2009.02.041
7
Ankit Bharat, Traves Crabtree. Management of Advanced-Stage Operable Esophageal CancerSurgical Clinics of North America 2012; 92(5): 1179 doi: 10.1016/j.suc.2012.07.012
8
Hae Jin Shin, Hee Seok Moon, Sun Hyung Kang, Jae Kyu Sung, Hyun Yong Jeong, Seok Hyun Kim, Byung Seok Lee, Ju Seok Kim, Gee Young Yun. Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinomaMedicine 2017; 96(51): e9441 doi: 10.1097/MD.0000000000009441
9
Lei Zhao, Li-Ru He, Rui Zhang, Mu-Yan Cai, Yi-Ji Liao, Dong Qian, Mian Xi, Yi-Xin Zeng, Dan Xie, Meng-Zhong Liu. Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinomaMedical Oncology 2012; 29(4): 2669 doi: 10.1007/s12032-011-0133-4
10
M. Hurmuzlu, O. R. Monge, R. Smaaland, A. Viste. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcomeDiseases of the Esophagus 2010; 23(3): 244 doi: 10.1111/j.1442-2050.2009.00999.x
11
Minghuan Li, Xiaoli Zhang, Fen Zhao, Yijun Luo, Li Kong, Jinming Yu. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practiceRadiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0589-7
12
Yuki Wada, Akira Anbai, Noriko Takagi, Satoshi Kumagai, Eriko Okuyama, Hiroshi Nanjo, Yusuke Sato, Satoru Motoyama, Manabu Hashimoto. Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center StudyCancers 2020; 13(1): 8 doi: 10.3390/cancers13010008
13
Hamid Yimam Hassen, Mohammed Ahmed Teka, Adamu Addisse. Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort StudyFrontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.594342
14
D. Tougeron, J.-P. Richer, C. Silvain. Management of esophageal adenocarcinomaJournal of Visceral Surgery 2011; 148(3): e161 doi: 10.1016/j.jviscsurg.2011.05.008
15
P. Michel, I. Iwanicki-Caron, F. Di Fiore. Thérapeutique du cancer2011; : 327 doi: 10.1007/978-2-8178-0021-9_21
16
Tyler R. Grenda, Andrew C. Chang. Difficult Decisions in Thoracic SurgeryDifficult Decisions in Surgery: An Evidence-Based Approach 2014; 1: 301 doi: 10.1007/978-1-4471-6404-3_24
17
Xiao-Li Yu, Jin Yang, Ting Chen, Yi-min Liu, Wei-ping Xue, Ming-Hui Wang, Shou-Min Bai. Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant ChemotherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6075207
18
I-Ying Kuo, Yu-Lin Huang, Chien-Yu Lin, Chien-Hsun Lin, Wei-Lun Chang, Wu-Wei Lai, Yi-Ching Wang. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genesJournal of Biomedical Science 2019; 26(1) doi: 10.1186/s12929-019-0510-4
19
Guillaume Piessen, Mathieu Messager, Xavier Mirabel, Nicolas Briez, William B. Robb, Antoine Adenis, Christophe Mariette. Is There a Role for Surgery for Patients with a Complete Clinical Response after Chemoradiation for Esophageal Cancer? An Intention-to-Treat Case-Control StudyAnnals of Surgery 2013; 258(5): 793 doi: 10.1097/SLA.0000000000000228
20
Lei Zhao, Feng Chi, Mian Xi, Jing-Xian Shen, Qiao-Qiao Li, Li-Ru He, Shi-Liang Liu, Meng-Zhong Liu. Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinomaBiomedicine & Pharmacotherapy 2015; 74: 148 doi: 10.1016/j.biopha.2015.08.021
21
A.A. Aaldriks, E. Maartense, S. le Cessie, E.J. Giltay, H.A.C.M. Verlaan, L.G.M. van der Geest, W.M. Kloosterman-Boele, M.T. Peters-Dijkshoorn, B.A. Blansjaar, H.W. van Schaick, J.W.R. Nortier. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapyCritical Reviews in Oncology/Hematology 2011; 79(2): 205 doi: 10.1016/j.critrevonc.2010.05.009
22
Guillaume Piessen, Nicolas Briez, Jean-Pierre Triboulet, Christophe Mariette. Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery?Annals of Surgical Oncology 2007; 14(7): 2036 doi: 10.1245/s10434-007-9405-9
23
Seok Yun Kang, Jae Ho Han, Kwang Jae Lee, Jin-Hyuk Choi, Jung Il Park, Hyoung Il Kim, Hyun-Woo Lee, Jun Ho Jang, Joon Seong Park, Hugh Chul Kim, Seunghee Kang, Young Taek Oh, Mison Chun, Jang Hee Kim, Seung Soo Sheen, Ho-Yeong Lim. Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive ChemoradiotherapyClinical Cancer Research 2007; 13(14): 4146 doi: 10.1158/1078-0432.CCR-06-3063
24
Zhen-Bin Ma, Guang-Hong Guo, Qiong Niu, Ning Shi. Role of EZH2 Polymorphisms in Esophageal Squamous Cell Carcinoma Risk in Han Chinese PopulationInternational Journal of Molecular Sciences 2014; 15(7): 12688 doi: 10.3390/ijms150712688
25
Dong-Churl Suh, Christopher A. Powers, Joseph A. Barone, HyunChul Shin, Jinweon Kwon, Susan Goodin. Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting studyResearch in Social and Administrative Pharmacy 2010; 6(3): 246 doi: 10.1016/j.sapharm.2009.07.004
26
Martine Extermann, Arti Hurria. Comprehensive Geriatric Assessment for Older Patients With CancerJournal of Clinical Oncology 2007; 25(14): 1824 doi: 10.1200/JCO.2007.10.6559
27
V. Prevost, C. Joubert, N. Heutte, E. Babin. Évaluation du statut nutritionnel et qualité de vie en cancérologie ORLAnnales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 2014; 131(2): 99 doi: 10.1016/j.aforl.2014.02.011
28
Hirotake Saito, Atsushi Ohta, Eisuke Abe, Motoki Kaidu, Miki Shioi, Toshimichi Nakano, Tomoya Oshikane, Kensuke Tanaka, Katsuya Maruyama, Naotaka Kushima, Satoshi Tanabe, Satoru Utsunomiya, Ryuta Sasamoto, Hidefumi Aoyama. Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patientsClinical and Translational Radiation Oncology 2018; 9: 12 doi: 10.1016/j.ctro.2017.12.003
29
S. Lecleire, M. Antonietti, I. Iwanicki-Caron, A. Duclos, F. Lemoine, F. L. Pessot, P. Michel, P. Ducrotté, F. Di Fiore. Lugol chromo-endoscopy versus Narrow Band Imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility studyDiseases of the Esophagus 2011; 24(6): 418 doi: 10.1111/j.1442-2050.2010.01164.x
30
Emilie Ferrat, Etienne Audureau, Elena Paillaud, Evelyne Liuu, Christophe Tournigand, Jean-Leon Lagrange, Florence Canoui-Poitrine, Philippe Caillet, Sylvie Bastuji-Garin. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA CohortThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2016; 71(12): 1653 doi: 10.1093/gerona/glw052
31
Wei-Lun Chang, Wu-Wei Lai, I-Ying Kuo, Chien-Yu Lin, Pei-Jung Lu, Bor-Shyang Sheu, Yi-Ching Wang. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinomaJournal of Gastroenterology 2017; 52(6): 705 doi: 10.1007/s00535-016-1265-2
32
X.-F. Cao, X.-T. He, L. Ji, J. Xiao, J. Lv. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinomaDiseases of the Esophagus 2009; 22(6): 477 doi: 10.1111/j.1442-2050.2008.00910.x
33
Jin Lü, Xiufeng Cao, Bin Zhu, Lü Ji. A prospective study: intraoperative 125I radioactive seed implant therapy in advanced esophageal squamous cell carcinomaJournal of Nanjing Medical University 2009; 23(5): 335 doi: 10.1016/S1007-4376(09)60080-0
34
HONG-YU XU, ZE-DONG DU, LIN ZHOU, MIN YU, ZHEN-YU DING, YOU LU. Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinomaOncology Letters 2014; 7(1): 260 doi: 10.3892/ol.2013.1694
35
Dae-Eun Kim, Uh-Jin Kim, Won-Young Choi, Mi-Young Kim, Seung-Hun Kim, Min-Jee Kim, Hyun-Jeong Shim, Jun-Eul Hwang, Woo-Kyun Bae, Ik-Joo Chung, Taek-Keun Nam, Kook-Joo Na, Sang-Hee Cho. Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive ChemoradiotherapyCancer Research and Treatment 2013; 45(4): 276 doi: 10.4143/crt.2013.45.4.276
36
Emilie Ferrat, Elena Paillaud, Marie Laurent, Aurélie Le Thuaut, Philippe Caillet, Christophe Tournigand, Jean-Léon Lagrange, Florence Canouï-Poitrine, Sylvie Bastuji-Garin. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With CancerThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2015; 70(9): 1148 doi: 10.1093/gerona/glv025
37
Yusuke Uchinami, Miyako Myojin, Hiroaki Takahashi, Keiichi Harada, Shinichi Shimizu, Masao Hosokawa. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosaRadiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0660-4
38
Yuanwei Huang, Haidong Wang, Ganfeng Luo, Yanting Zhang, Li Wang, Ke Li. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinomaInternational Journal of Surgery 2017; 38: 41 doi: 10.1016/j.ijsu.2016.12.035
39
D. Tougeron, J.-P. Richer, C. Silvain. Traitement des adénocarcinomes de l’œsophageJournal de Chirurgie Viscérale 2011; 148(3): 184 doi: 10.1016/j.jchirv.2011.03.011
40
Williams Tessier, Guillaume Piessen, Nicolas Briez, Arianna Boschetto, Géraldine Sergent, Christophe Mariette. Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapySurgical Endoscopy 2013; 27(2): 633 doi: 10.1007/s00464-012-2506-y
41
Zhenhuan Zhao, Yixue Wen, Dongbiao Liao, Jidong Miao, Yan Gui, Hongwei Cai, Yang Chen, Min Wei, Qiang Jia, Honggang Tian, Mingqiang Sun, Yu Zhang, Gang Feng, Xiaobo Du. Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical TrialThe Oncologist 2020; 25(12): e1900 doi: 10.1634/theoncologist.2020-0808
42
Jacqueline Bauer, Heribert Jürgens, Michael C. Frühwald. Important Aspects of Nutrition in Children with CancerAdvances in Nutrition 2011; 2(2): 67 doi: 10.3945/an.110.000141
43
Frédéric Di Fiore, Stéphane Lecleire, Daniela Pop, Olivier Rigal, Hadji Hamidou, Bernard Paillot, Philippe Ducrotté, Eric Lerebours, Pierre Michel. Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal CancerThe American Journal of Gastroenterology 2007; 102(11): 2557 doi: 10.1111/j.1572-0241.2007.01437.x
44
Li-Ru He, Meng-Zhong Liu, Bin-Kui Li, Hui-Lan Rao, Hai-Xia Deng, Xin-Yuan Guan, Yi-Xin Zeng, Dan Xie. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinomaCancer Science 2009; 100(9): 1591 doi: 10.1111/j.1349-7006.2009.01224.x
45
HAIPING YANG, LIJUAN XU, HAILI QIAN, XINQIANG NIU, DAN ZHAO, ZHILONG ZHAO, JUN WU, JUNFENG LIU, YANYU WANG. Correlation between insulin-like growth factor binding protein 3 and metastasis-associated gene 1 protein in esophageal squamous cell carcinomaMolecular Medicine Reports 2016; 13(5): 4143 doi: 10.3892/mmr.2016.5046
46
D Tougeron, F Di Fiore, S Thureau, N Berbera, I Iwanicki-Caron, H Hamidou, B Paillot, P Michel. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancerBritish Journal of Cancer 2008; 99(10): 1586 doi: 10.1038/sj.bjc.6604749
47
Su Youn Nam, Seong Woo Jeon, Sang Jik Lee, Yong Hwan Kwon, Hyun Seok Lee, Sung Kook Kim. Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer PatientsGut and Liver 2020; 14(4): 450 doi: 10.5009/gnl19165
48
V. Prevost, C. Joubert, N. Heutte, E. Babin. Assessment of nutritional status and quality of life in patients treated for head and neck cancerEuropean Annals of Otorhinolaryngology, Head and Neck Diseases 2014; 131(2): 113 doi: 10.1016/j.anorl.2013.06.007